Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-05
2011-04-05
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S309000, C546S148000, C546S196000
Reexamination Certificate
active
07919508
ABSTRACT:
The present invention provides compounds of formula I:a stereoisomer or a pharmaceutically acceptable salt thereof, wherein the variables R1, R2, R3, R4, X and n are defined as defined herein. Additionally, a method for treating dopamine-related neurological disorders selected form the group consisting of neurological, psychological, cardiovascular, cognitive or attention disorders, substance abuse and addictive behavior, or a combination thereof, comprising administering to a patient in need of such treatment a therapeutically effective amount of compounds of formula I.
REFERENCES:
patent: 6004982 (1999-12-01), Stupczewski et al.
patent: WO 98/34933 (1988-08-01), None
Angelastro Michael R.
Bomont Catherine
Bordeau Kenneth J.
Harris Keith J.
John Stanly
Aventis Pharmaceuticals Inc.
Chang Celia
Lin Jiang
LandOfFree
3-piperidinylisochroman-5-ols as dopamine agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-piperidinylisochroman-5-ols as dopamine agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-piperidinylisochroman-5-ols as dopamine agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2721567